trending Market Intelligence /marketintelligence/en/news-insights/trending/avdrxcggaypnom8jupmw3g2 content esgSubNav
In This List

Biostage enters stock purchase agreement, names president

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Biostage enters stock purchase agreement, names president

Biostage Inc. will sell between 500,000 and 1 million shares under a share purchase agreement.

The Holliston, Mass.-based biotechnology company agreed to sell the shares, priced at $3.60 each, to an investor named Du Xiaoyu, who will determine the number of shares to be bought on or before June 29.

Biostage will raise between $1.8 million and $3.6 million through the private placement, which is expected to close in late June or early July.

The company also closed two previously announced, similar placements of $3.6 million in shares.

Additionally, Biostage appointed Hong Yu as president.

Yu was most recently senior vice president responsible for strategic analytics at Bank of America. He previously assisted Biostage with strategic activities.